Optimizing Hepatitis C Virus (HCV) Treatment in a US Colocated HCV/Opioid Agonist Therapy Program

BACKGROUND: A minority of patients with opioid use disorder are treated for hepatitis C virus infection (HCV). While colocated HCV and opioid agonist therapy (OAT) along with harm reduction can facilitate prevention and cascade to cure, there are few real-world examples of such embedded care models...

Descripción completa

Detalles Bibliográficos
Autores principales: Habchi, Jackie, Thomas, Aurielle M, Sprecht-Walsh, Sophie, Arias, Elenita, Bratberg, Jeffrey, Hurley, Linda, Hart, Susan, Taylor, Lynn E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550646/
https://www.ncbi.nlm.nih.gov/pubmed/33072802
http://dx.doi.org/10.1093/ofid/ofaa310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550646/
https://www.ncbi.nlm.nih.gov/pubmed/33072802
http://dx.doi.org/10.1093/ofid/ofaa310

Ejemplares similares